ROME THERAPEUTICS
Live / Allowed — Fifth extension granted (statement of use) (as of 12 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Dec 2021 filing date already counts against anyone who files later.
Record
- Serial number
- 97187987
- Mark type
- Stylized text
- Filed
- 23 Dec 2021
- Published for opposition
- 29 Nov 2022
- Attorney of record
- Glenn A. Gundersen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of oncology, autoimmune, neurodegenerative, and other related diseases; veterinary preparations for the treatment of oncology, autoimmune, neurodegenerative, and other related diseases
Owner
- ROME Therapeutics, Inc., Boston, MA, US
- Rome Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 13 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Nov 2025 — SOU EXTENSION 5 GRANTED
- 23 Jul 2025 — SOU EXTENSION 5 FILED
- 12 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jan 2025 — SOU EXTENSION 4 GRANTED
- 24 Jan 2025 — SOU EXTENSION 4 FILED
- 24 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jul 2024 — SOU EXTENSION 3 GRANTED
- 18 Jul 2024 — SOU EXTENSION 3 FILED
- 18 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 11 Mar 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 11 Mar 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL